Neogen
NEOG
337 hedge funds and large institutions have $4.27B invested in Neogen in 2024 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 129 increasing their positions, 118 reducing their positions, and 30 closing their positions.
288% more call options, than puts
Call options by funds: $3.37M | Put options by funds: $868K
9% more capital invested
Capital invested by funds: $3.93B → $4.27B (+$337M)
1.17% more ownership
Funds ownership: 116.04% → 117.21% (+1.2%)
9% more repeat investments, than reductions
Existing positions increased: 129 | Existing positions reduced: 118
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
2% less funds holding
Funds holding: 345 → 337 (-8)
10% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 30
Top Buyers
Top Sellers
| 1 |
RC
Rivulet Capital
Summit,
New Jersey
|
-$46.2M |
| 2 |
Select Equity Group
New York
|
-$37.7M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$27.6M |
| 4 |
OAM
Ophir Asset Management
Sydney,
Australia
|
-$26.2M |
| 5 |
Millennium Management
New York
|
-$15.7M |
NEOG Hedge Fund Activity: Q3 2024 in Review
337 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Neogen (NEOG) for Q3 2024, worth a combined $4.27B — up 8.6% from $3.93B a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of NEOG and 27 opened new positions — a net loss of 3 holders — while 118 trimmed existing stakes and 129 added.
The largest buyer was Fred Alger Management, adding an estimated $30.4M. The largest seller was Rivulet Capital, cutting an estimated $46.2M.
- 337 institutional investors held Neogen (NEOG) as of Q3 2024, down from 345 in Q2 2024.
- Funds reported $4.27B of Neogen stock for Q3 2024, up 8.6% quarter-over-quarter.
- 27 funds opened new Neogen positions in Q3 2024 and 30 closed out, a net change of -3 holders.
- The largest Neogen buyer in Q3 2024 was Fred Alger Management, an estimated $30.4M added.
- The largest Neogen seller in Q3 2024 was Rivulet Capital, an estimated $46.2M sold.
Based on aggregated 13F filings for Q3 2024.